Chendil Damodaran
Impact in
-
- Phytochemicals and Medicinal Plants
- Medicinal Plants and Neuroprotection
- Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents
Papers in
- Toxicology 10
- Bioactive Compounds and Antitumor Agents 10
-
- Phytochemicals and Medicinal Plants 18
- Co-authors
- Sowmyalakshmi SrinivasanTrinath P. DasMurali K. AnkemSuman SumanRama S. RangaMansoor M. AhmedAshish TyagiSrinivas V. Koduru
- Journals
- Cancer Research (7 papers)Urologic Oncology Seminars and Original Investigations (5 papers)Molecular Carcinogenesis (4 papers)Cancer Letters (3 papers)Molecular Cancer Therapeutics (3 papers)
- Partner nations
- United StatesIndiaSpain
In The Last Decade
Chendil Damodaran
86 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 117
- Complementary and alternative medicine 558
- Toxicology 217
- Cancer Research 520
- Molecular Medicine 162
- Molecular Biology 1.7k
Countries citing papers authored by Chendil Damodaran
This map shows the geographic impact of Chendil Damodaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chendil Damodaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chendil Damodaran more than expected).
Fields of papers citing papers by Chendil Damodaran
This network shows the impact of papers produced by Chendil Damodaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chendil Damodaran. The network helps show where Chendil Damodaran may publish in the future.
Co-authors
The 25 scholars most cited alongside Chendil Damodaran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 5 | |
| 4 | 2020 | 9 | |
| 5 | 2020 | 5 | |
| 6 | 2018 | 25 | |
| 7 | 2018 | 34 | |
| 8 | 2014 | 28 | |
| 9 | 2014 | 165 | |
| 10 | 2013 | 80 | |
| 11 | 2013 | 123 | |
| 12 | 2009 | 133 | |
| 13 | 2006 | 181 | |
| 14 | Apoptosis regulation by androgen receptor (AR) in prostate cancer biology | 2006 | 1 |
| 15 | Effect of Diosgenin (Fenugreek) on breast cancer cells | 2005 | 7 |
| 16 | Quantitative and qualitative analysis of effect of potential drug target knockdown on soft agar colony formation utilizing Qcount™ automated analysis system. | 2004 | 1 |
| 17 | 2004 | 35 | |
| 18 | 2001 | 56 | |
| 19 | 2001 | 17 | |
| 20 | 1996 | 22 |
About Chendil Damodaran
Chendil Damodaran is a scholar working on Toxicology, Complementary and alternative medicine, Cancer Research, Health, Toxicology and Mutagenesis and Oncology, having authored 88 papers that have together received 3.4k indexed citations. Recurring topics across this work include Phytochemicals and Medicinal Plants (18 papers), Heavy Metal Exposure and Toxicity (13 papers), Cancer-related Molecular Pathways (12 papers), Bioactive Compounds and Antitumor Agents (10 papers), Autophagy in Disease and Therapy (8 papers), Prostate Cancer Treatment and Research (7 papers), Cell death mechanisms and regulation (6 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). The work is most often cited by research in Complementary and alternative medicine (558 citations), Toxicology (217 citations), Cancer Research (520 citations), Molecular Medicine (162 citations) and Molecular Biology (1.7k citations). Chendil Damodaran has collaborated with scholars based in United States, India and Spain. Frequent co-authors include Sowmyalakshmi Srinivasan, Trinath P. Das, Murali K. Ankem, Suman Suman, Rama S. Ranga, Mansoor M. Ahmed, Ashish Tyagi, Srinivas V. Koduru, Raj Kumar and Arun Sharma. Their work appears in journals such as Cancer Research, Urologic Oncology Seminars and Original Investigations, Molecular Carcinogenesis, Cancer Letters and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.